Quick Answer
COSCIENS Biopharma Inc. reported Total Assets of $21.43 million for fiscal year 2025.
COSCIENS Biopharma Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $21.43M -38.9% |
$35.07M +47.7% |
$23.75M -37.1% |
$37.73M -52.9% |
$80.10M +116.5% |
$37.01M +85.2% |
| R&D Expense | $2.95M -64.5% |
$8.30M +307.1% |
$2.04M +48.8% |
$1.37M -79.1% |
$6.57M +336.5% |
$1.51M -18.0% |
| Gross Profit | $2.65M -44.0% |
$4.73M +61.0% |
$2.94M -73.3% |
$11.02M | — | — |
- COSCIENS Biopharma Inc. reported Total Assets of $21.43 million for fiscal year 2025.
- COSCIENS Biopharma Inc. showed a decrease of -38.9% in Total Assets compared to the prior fiscal year.
- COSCIENS Biopharma Inc. reported R&D Expense of $2.95 million for fiscal year 2025.
- COSCIENS Biopharma Inc. showed a decrease of -64.5% in R&D Expense compared to the prior fiscal year.
- COSCIENS Biopharma Inc. reported Gross Profit of $2.65 million for fiscal year 2025.
- COSCIENS Biopharma Inc. showed a decrease of -44.0% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: